314042-01-8
基本信息
SID57578339
CID-1067700
2-(Benzoylcarbamothioylamino)-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic Acid
CID-1067700,2-(3-benzoylthioureido)-5,5-diMethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylic acid
2-[[(Benzoylamino)thioxomethyl]amino]-4,7-dihydro-5,5-dimethyl-5H-thieno[2,3-c]pyran-3-carboxylic acid
5H-Thieno[2,3-c]pyran-3-carboxylic acid, 2-[[(benzoylamino)thioxomethyl]amino]-4,7-dihydro-5,5-dimethyl-
物理化學(xué)性質(zhì)
報(bào)價(jià)日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價(jià)格 |
2024/11/08 | HY-13452 | 2-[[(苯甲?;被?硫代甲酰]氨基]-4,7-二氫-5,5-二甲基-5H-噻吩并[2,3-C]吡喃-3-羧酸 CID-1067700 | 314042-01-8 | 5mg | 700元 |
2024/11/08 | HY-13452 | 2-[[(苯甲?;被?硫代甲酰]氨基]-4,7-二氫-5,5-二甲基-5H-噻吩并[2,3-C]吡喃-3-羧酸 CID-1067700 | 314042-01-8 | 10mM * 1mLin DMSO | 770元 |
2024/11/08 | HY-13452 | 2-[[(苯甲酰基氨基)硫代甲酰]氨基]-4,7-二氫-5,5-二甲基-5H-噻吩并[2,3-C]吡喃-3-羧酸 CID-1067700 | 314042-01-8 | 10mg | 1120元 |
常見問題列表
Ki: 13 nM (Rab7)
CID-1067700 (ML282) is a pan GTPase inhibitor, and competitively inhibits Rab7 with a K i of 13 nM. CID-1067700 shows inhibitory activity against nucleotide binding by Rab7, with K d s of 100 nM and 40 nM for BODIPY-GTP and BODIPY-GDP, respectively. With increasing concentration, CID-1067700 causes strong inhibition on binding of the BODIPY-linked nucleotides, with EC 50 values of 11.22 ± 1.34 nM for BODIPY-GTP and 20.96 ± 1.34 nM for BODIPY-GDP and calculated K i values of 12.89 nM and 19.70 nM respectively. CID-1067700 (10 μM) has no effect on the rate of release of bound BODIPY-linked nucleotide by wild type Rab7 under equilibrium binding conditions. CID-1067700 (0-40 μM) inhibits Rab7 activity, NF-κB activation as well as AID induction in B cells. Furthermore, CID-1067700 binds Rab7 with a high affinity (EC 50 : 10-20 nM), and blocks Class switch DNA recombination (CSR) in B cells via targeting Rab7.
CID-1067700 (ML282; 16 mg/kg, i.p.) prevents disease development in lupus-prone mice by Rab7 inhibition, and reduces IgG-IC deposition in MRL/ Fas lpr/lpr mice. CID-1067700 also targets B cells and specifically impairs the CSR machinery in vivo.